Replies to post #6070 on Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[Altitrade Partners]

Money. Specifically, the funding of the Phase III clinical trial.

It makes no sense to go through the process of obtaining compliance with SEC Rule 15c2-11 without being able to move the company forward.